Materials and Methods

Subjects.
We studied 46 control subjects. Of these, 29 were examined during a stay in the hospital (in the ophthalmologic, orthopedic, or internal medicine ward), and 17 during a clinical examination for recruitment of university personnel.
All were free of any obvious medical disease. Twenty-five were men, 21 women. Women taking oral contraceptives were not included as it is known that these drugs influence values for serum copper (17) (18) (19) (20) and zinc (18) . We studied 16 patients with acute myocardial infarction. From eight (six men and two women, age 33 to 84 years, mean age 63 years), blood samples were collected on admission to the hospital. Chest pain had started 2 h to 3.5 days (mean, 28 h) before. From the eight others (all men, age 42 to 68 years, mean age 58 years), blood samples were collected while they were under treatment in the intensive-care unit. Chest pain had started 27 h to 4.5 days (mean, 52 h) before. Treatment included analgesics and sedatives and in some cases sodium warfarmn, lanatoside C, furosemide, or chiorthalidone. In one case, betamethasone and aminophylline were also administered because of associated bronchial asthma. All patients were al4o given intravenous glucose (50 g/liter, 1 to 1.5 liters per 24 h).
Every case of acute myocardial infarction was documented by electrocardiogram and increased serum enzyme activity (aminotransferases, lactate dehydrogenase, creatine kinase).
In the case of control subjects and the patients hospitalized in the intensive-care unit, blood was sampled between 0800 and 1000 h, after an overnight fast.
Four of the hospitalized controls received intravenous glucose, as did the patients with myocardial in-farction. Serum manganese, copper, and zinc were determined before and at the end of the infusion.
Techniques.
Serum manganese, copper, and zinc were determined by neutron activation analysis. Collection of blood specimens, sample and standard handling, irradiation, chemical separations, and measurements were carried out as described elsewhere (12) . However, the blood samples were collected with a plastic cannula trocar (Intranule, 110 16 , Vygon Sterile) instead of with a disposable steel needle (Terumo, 18 G 1%) as mentioned in the original report (12) . It is of paramount importance to take the utmost care to avoid all possible sources of contamination (9, 11, 13, 15) . The serum samples were irradiated for 4 h in the Thetis reactor of Ghent University at a flux of 1.9 X 1012 n . cm2 s1. The neutron spectrum of the reactor being stable, a copper wire co-irradiated with the samples was used as a flux monitor (single comparator method). Beforehand, we evaluated the ratios of the specific photopeak activities of the isotopes investigated to the specific photopeak activity of the copper monitor measured in welldefined experimental conditions (21) . All samples were analyzed in duplicate and the mean value was calculated.
Statistical methods.
The values obtained for healthy subjects were tested for outlying observations according to the criteria of Grubbs (22) (12) .
Secondly, the percent difference (d) between the two results of the duplicate determinations also permitted an estimate of the standard deviation. The calculations were made as follows (25) :
where n is the number of duplicate determinations performed. We obtained the following values for manganese: s = 12.9% (controls) and 12 .8% (patients with acute myocardial infarction); for copper the values were respectively s = 5.6% and 5.1%; and for zinc they were s = 7.3%and 6.5%.
The accuracy of the neutron activation technique for determining copper and zinc in serum was checked by comparing the results with those obtained by atomic absorption in a same pooled serum. The mean value determined by neutron activation was 3.9% higher (for copper) and 5.6% lower (for zinc) (14) .
Results
The individual values for serum manganese, copper, and zinc in controls and in patients with acute myocardial infarction are plotted in Figure 1A , B, and C.
In the controls the distributions are normal but the following values are outlying: 1.01 and 1.04 gig/liter (manganese) and 1.99 mg/liter (copper).
In the patients with acute myocardial infarction, the mean serum manganese, copper, and zinc values on admission do not significantly differ from the mean values during hospitalization, so all the patients are treated as one group.
The means ±1 SD for the controls are 0.57 ± 0.13 tg/liter (serum manganese), 1.07 ± 0.24 mg/liter (serum copper), and 0.94 ± 0.13 mg/liter (serum zinc). These results were previously reported in this journal (16) .
The means ±1 SD for the patients with myocardial infarction are 0.64 ± 0.10 sg/liter (serum manganese), 1 (not significant, 0.50 <p < 0.60). Glucose infusion did not modify the serum manganese, copper, or zinc concentrations in the four controls.
Discussion
Manganese.
An earlier report by Hedge et al. (1) describingan increased serum manganese after myocardial infarction is based on analyses of contaminated samples. It now has been proved that the true serum manganese concentration in normal subjects (9) (10) (11) (12) (13) is about 0.600 sg/liter, not 10 gig/liter (1). Our results show that serum manganese concentrations do not significantly increase after myocardial infarction and that no significant correlation exists between serum manganese and aspartate aminotransferase.
Thus, in our experience serum manganese values do not provide an indication of myocardial damage.
Copper.
The serum copper concentration reportedly increases in acute myocardial infarction ordinarily beginning on the second or third day (3) , reaching a maximum on the fourth to the sixth day (2) or on the fifth to the eleventh day (3), and gradually decreasing to normal within three (2) or several (3) weeks. In the present study a slight but statistically significant increase in serum copper was found. The highest two values obtained are 1.62 mg/liter (65-year-old man, 48 h after onset of chest pain) and 1.74 mg/liter (42-year-old man, about 4 days after onset of symptoms).
Possible explanations for the increase of serum copper are discussed by Khandekar etal. (2) .
Zinc.
It now seems firmly established that the serum zinc concentration decreases after myocardial infarction (4) (5) (6) (7) (8) .
Halsted and Smith (4) say that the value decreases within 24-48 h. Davies et al. (26) mention six patients with coronary infarction who had a serum zinc value within the normal range; this must not be interpreted as contradictory-their samples were taken "within the first two weeks" after the acute infarction. Halsted and Smith (4) and Wacker et al. (8) report that low values persist for two weeks. More recently, however, Handjani et al. (5) reported that the mean concentration increases again on the fifth day and that all values exceed the minimal normal by the tenth day, which agrees with the findings of Lindeman et al. (6) , who have also shown that the mean concentration increases again on the fourth and fifth day, reaching again control values. Our findings are in good agreement with those of others Because plasma zinc responds to food intake (26) (27) (28) , we were careful in the case of the patients examined on admission that no blood specimens were collected within 3 h after the last meal. However, in these eight patients a possible diurnal variation could also influence the results. Significant diurnal variations have both been described (29, 30) and denied (4) . An intravenous glucose load can cause plasma zinc to decrease (26, 27) . However, glucose infusion, as in the hospitalized patients with myocardial infarction, did not significantly influence serum zinc values.
To our knowledge it has not been described that therapeutic doses of the drugs used during this study influence the concentrations in serum of the trace elements involved. Wester (31) 
